Veeva Announces MyVeeva to Enable Patient-Centric Clinical Trials
Go back to Veeva Announces MyVeeva to Enable Patient-Centric Clinical Trials| VEEVA SYSTEMS, Inc. (NYSE: VEEV) | Delayed: 244.91 -1.87 (0.76%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $246.78 | 52 Week High | $42.58 | |||
| Open | $239.87 | 52 Week Low | $19.97 | |||
| Day High | $247.70 | P/E | 8,163.67 | |||
| Day Low | $238.93 | EPS | $0.03 | |||
| Volume | 1,455,932 | |||||

